Salouage Issam, El Aidli Sihem, Kastalli Sarra, Daghfous Riadh, Lakhal Mohamed
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Centre national de pharmacovigilance, 9, rue Dr Zouhaier-Essafi, 1006 Tunis, Tunisia.
Therapie. 2016 Dec;71(6):535-539. doi: 10.1016/j.therap.2016.06.004. Epub 2016 Jul 21.
Anaphylactic reactions are often induced by drugs, and the most frequent ones are penicillin derivates. The concurrence of acute coronary syndrome with hypersensitivity and anaphylactic or anaphylactoid reactions constitutes the Kounis syndrome. We report a case of a coronary stent thrombosis with a fatal outcome complicating an anaphylactic shock induced by amoxicillin-clavulanic acid association. A 58-year-old woman with a history of triple coronary stenting was treated by amoxicillin/clavulanic acid association for pharyngitis. One hour after the first drug intake, she developed an anaphylactic shock with acute constricting chest pain. She received intravenous hydrocortisone and was transferred to emergency department. The patient received epinephrine intravenously with fluid perfusion and oxygen. Electrocardiogram showed Pardee waves in the anterior precordial leads. Cardiac enzyme levels (troponin I) were disturbed. The patient was transferred to the coronary care unit with a diagnosis of acute myocardial infarction. The coronary angiography revealed anterior interventricular stent thrombosis. The patient experienced a cardiogenic shock with an important hemodynamic repercussion, and she died few hours later despite emergency care. The responsibility of amoxicillin-clavulanic acid association was retained in the genesis of this anaphylactic shock in front of a suggestive delay, a compatible evolution and a high semiotic score. Amoxicillin/clavulanic acid use may cause Kounis syndrome. The use of epinephrine is a challenging decision. We suggest that Kounis syndrome should be considered in the differential diagnosis of acute coronary syndrome.
过敏反应常由药物诱发,最常见的是青霉素衍生物。急性冠状动脉综合征与超敏反应以及过敏或类过敏反应同时出现构成库尼斯综合征。我们报告一例因阿莫西林 - 克拉维酸联合用药诱发过敏性休克并发致命性冠状动脉支架血栓形成的病例。一名有冠状动脉三支血管支架置入史的58岁女性因咽炎接受阿莫西林/克拉维酸联合治疗。首次服药1小时后,她出现过敏性休克并伴有急性压榨性胸痛。她接受了静脉注射氢化可的松并被转至急诊科。患者接受了静脉注射肾上腺素、液体灌注和吸氧治疗。心电图显示胸前导联出现帕迪波。心肌酶水平(肌钙蛋白I)异常。患者被转至冠心病监护病房,诊断为急性心肌梗死。冠状动脉造影显示前室间支支架血栓形成。患者出现心源性休克并伴有严重的血流动力学影响,尽管进行了急救,数小时后仍死亡。鉴于存在提示性的时间延迟、相符的病情进展和较高的症状评分,阿莫西林 - 克拉维酸联合用药被认为是此次过敏性休克的病因。使用阿莫西林/克拉维酸可能会导致库尼斯综合征。使用肾上腺素是一个具有挑战性的决定。我们建议在急性冠状动脉综合征的鉴别诊断中应考虑库尼斯综合征。